Yaoxin Gao
Shanghai Key Laboratory Of Regulatory Biology
Shanghai, 200241, China
Shanghai, 200241, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
RAE1-armoured DC vaccine boosts NKG2D-CAR-T cells elicited anti-solid tumour treatment.
Journal: Pharmacological research
Published: January 30, 2025
Co-expression of IL-15/IL-15Ra complex enhances NKG2D-CAR T cell-mediated anti-pancreatic cancer immunity by activating the JAK/STAT5 signaling pathway.
Journal: Frontiers in immunology
Published: September 19, 2024
GPR97 depletion aggravates imiquimod-induced psoriasis pathogenesis via amplifying IL-23/IL-17 axis signal pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 25, 2024
Intrinsic ADRB2 inhibition improves CAR-T cell therapy efficacy against prostate cancer.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 07, 2024
Co-expression of IL-4/IL-15-based inverted cytokine receptor in CAR-T cells overcomes IL-4 signaling in immunosuppressive pancreatic tumor microenvironment.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 29, 2023
GPR116 receptor regulates the antitumor function of NK cells via Gαq/HIF1α/NF-κB signaling pathway as a potential immune checkpoint.
Journal: Cell & bioscience
Published: December 16, 2022
Purinergic Receptor P2Y6 Is a Negative Regulator of NK Cell Maturation and Function.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: June 24, 2021
Obeticholic Acid Derivative, T-2054 Suppresses Osteoarthritis via Inhibiting NF-κB-Signaling Pathway.
Journal: International journal of molecular sciences
Published: March 10, 2021
CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1- Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells.
Journal: Cancers
Published: August 03, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026